Nomination Committee

Nomination Committee

The duties of the Nomination Committee include preparing and drafting of proposals for election and remuneration to the Chairman of the Board, members of the Board of Directors, committee members and auditors, the most recently proposed by the Audit Committee. The members of the Nomination Committee must safeguard the interests of all shareholders and not unduly disclose what has occurred in the Nomination Committee’s work. The Chairman of the Board or any other Board member shall not chair the Nomination Committee.

The Nomination Committee meets if necessary, but at least once a year. The term of office for the appointed nomination committee shall run until a new nomination committee is appointed.
At least six months before the AGM, the members of the Nomination Committee shall be announced on Isofol’s website.

In accordance with the principles for the appointment of the Nomination Committee of Isofol Medical AB (publ) adopted at the Annual General Meeting on May 23, 2019, the Nomination Committee for the Annual General Meeting 2020 shall consist of four members, of which one member shall be the Chairman of the Board. The other three members for the 2020 Annual General Meeting consist of representatives appointed by the three largest shareholders in the company for the number of votes at August 31, 2019:

  • Lars Lind, appointed by Biofol AB
  • Malin Björkmo, appointed by Handelsbanken Fonder
  • Bo Lundgren, appointed by Swedbank Robur Fonder
  • Mats-Ola Palm, appointed by at least 12% of the votes

The nomination committee’s proposals will be presented in the notice of the AGM and on the company’s website,

Shareholders who wish to submit proposals to the Nomination Committee can do so by sending an e-mail to (heading: “Isofol’s Nomination Committee”) or by letter at address:

Isofol Medical AB (publ)
Att. Valberedningen
Arvid Wallgrens Backe 20
413 46 Göteborg